Breakthrough Therapy designation

Breakthrough Therapy designation is a status granted by the FDA to expedite the development and review of drugs intended to treat serious or life-threatening conditions. It is given when preliminary clinical evidence shows the drug may offer substantial improvement over existing therapies. This designation allows for more frequent communication with the FDA, accelerated trials, and a faster review process, helping promising treatments reach patients more quickly while maintaining rigorous safety and effectiveness standards.